Clinical trial
Comparison Between Efficacy of Levetiracetam Versus Valproic Acid in Pediatric Patients With Status Epilepticus
NCT07052136 is registered in ClinicalTrials.gov with RESnTEC, Institute of Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison Between Efficacy of Levetiracetam Versus Valproic Acid in Pediatric Patients With Status Epilepticus
- Lead sponsor
- RESnTEC, Institute of Research
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 1, 2024
- Completion date
- April 30, 2025
- Enrollment
- 138 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.